[{"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0394-2024", "product_description": "Diltiazem HCl 125 mg in 0.9% Sodium Chloride Injection (Concentration = 1mg/mL), 125 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095; NDC 70004-0541-35, Bar Code 70004054135", "product_quantity": "381 Bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049625, Exp 1/24/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94550", "recalling_firm": "Revive Rx LLC dba Revive Rx Pharmacy", "address_1": "3831 Golf Dr Ste A", "address_2": "", "postal_code": "77018-5218", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0511-2024", "product_description": "Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64", "product_quantity": "751 vials", "reason_for_recall": "Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate", "recall_initiation_date": "20240420", "center_classification_date": "20240529", "report_date": "20240605", "code_info": "Lot #: 748127, Exp 9/24/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "94483", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0482-2024", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, (a) 90-count bottles (NDC 51991-747-90), (b) 1000-count bottles (NDC 51991-747-10), Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.", "product_quantity": "281,554/90 & 1000 count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240429", "center_classification_date": "20240504", "report_date": "20240515", "code_info": "220265: Exp. Feb 2025 220088: Exp. Nov 2024 220267: Exp. Feb 2025 220256: Exp. Feb 2025 220225: Exp. Jan 2025 220269: Exp. Feb 2025"}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0529-2024", "product_description": "NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Roll-On NET WT 3 fl. oz. (88.7ml), Manufactured for Golden Tiger USA Albuquerque, NM, UPC 1 82294 00006 2", "product_quantity": "1,680", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 17323C3, Exp 06/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["Meijer Distribution Inc"], "product_ndc": ["79481-0034"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["29f8fa4c-e1a4-3943-e063-6294a90a6b61"], "spl_set_id": ["f425a7aa-2503-2fe8-e053-2995a90ab352"], "package_ndc": ["79481-0034-9"], "is_original_packager": [true], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "94575", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0501-2024", "product_description": "Meijer Magnesium Citrate Saline Laxative Oral Solution Dye Free, Sugar Free Grape, 10 fl. oz bottle, Distributed by: Meijer Distribution Inc., Grand Rapids,MI 49544, NDC 79481-0034-9", "product_quantity": "24840", "reason_for_recall": "Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria", "recall_initiation_date": "20240501", "center_classification_date": "20240516", "report_date": "20240522", "code_info": "Lot #: A81834, Exp 1/31/2026"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0398-2024", "product_description": "fentaNYL 200 mcg/100 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Injection, (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0231-64, Bar Code 70004023164", "product_quantity": "613 Cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049754, Exp 01/12/24; 1223049992, Exp 01/23/24; 1223050066, Exp 01/25/24", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0414-2024", "product_description": "PHENYLephrine HCl 1000 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-12, Bar Code 70004081012", "product_quantity": "33,072 syringes; expanded 9,041 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223045536 Exp 12/06/23; 1223045710 Exp 12/10/23; 1223046574 Exp 01/12/24; 1223047579 Exp 02/21/24; 1223047764 Exp 03/06/24; 1223048363 Exp 03/30/24; 1223048364 Exp 03/30/24; 1223048566 Exp 04/06/24; 1223048573 Exp 04/07/24; 1223048574 Exp 04/07/24; 1223048643 Exp 04/11/24; 1223048697 Exp 04/12/24; 1223048742 Exp 04/13/24  Expanded lots#: 1223048065, Exp 04/06/2024; 1223048395, 1223048397, Exp 03/27/2024; 1223049980, Exp 06/05/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE"], "manufacturer_name": ["CVS Pharmacy, Inc."], "product_ndc": ["51316-881"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["2a807f1b-9870-a9ea-e063-6394a90aed25"], "spl_set_id": ["fb808dc5-bf80-836c-e053-6294a90a80aa"], "package_ndc": ["51316-881-10"], "is_original_packager": [true], "upc": ["0050428346495"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "94575", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA Nationwide", "recall_number": "D-0500-2024", "product_description": "CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Cherry Flavor, 10 fl. oz bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, NDC 51316-881-10.", "product_quantity": "120830", "reason_for_recall": "Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria", "recall_initiation_date": "20240501", "center_classification_date": "20240516", "report_date": "20240522", "code_info": "Lot #: A81506, Exp 12/31/2025"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202289"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-050", "33342-051", "33342-052"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["cf31d31e-9355-47da-9c2b-8e4b84ac8159"], "spl_set_id": ["a04b5622-2c49-4d61-92b1-5dc523af7a24"], "package_ndc": ["33342-050-07", "33342-050-10", "33342-050-44", "33342-050-12", "33342-051-07", "33342-051-10", "33342-051-44", "33342-051-12", "33342-052-07", "33342-052-10", "33342-052-44", "33342-052-12"], "is_original_packager": [true], "upc": ["0333342051448", "0333342050106", "0333342052100", "0333342051103", "0333342052445", "0333342051073", "0333342052070"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "94592", "recalling_firm": "MACLEODS PHARMA USA, INC", "address_1": "103 College Rd E Fl 2", "address_2": "N/A", "postal_code": "08540-6611", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "USA Nationwide", "recall_number": "D-0498-2024", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44", "product_quantity": "1,048 bottles", "reason_for_recall": "Presence of foreign substance: plastic-like substance.", "recall_initiation_date": "20240507", "center_classification_date": "20240515", "report_date": "20240522", "code_info": "Lot #: BLK2304A, Exp. 07/31/2025"}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "94483", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0483-2024", "product_description": "Duloxetine Delayed-Release Capsules, USP, 20 mg, , 500-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922, NDC 51991-746-05.", "product_quantity": "7,188/ 500 count bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240429", "center_classification_date": "20240504", "report_date": "20240515", "code_info": "220456: Exp. Feb 2025"}, {"status": "Completed", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078518"], "brand_name": ["VALACYCLOVIR HYDROCHLORIDE"], "generic_name": ["VALACYCLOVIR"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-4275", "0378-4276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALACYCLOVIR HYDROCHLORIDE"], "rxcui": ["313564", "313565"], "spl_id": ["f0f10f6e-5e47-4a5b-a70b-578199d3f0f0"], "spl_set_id": ["56bf715d-8280-4557-9f98-9693932199e5"], "package_ndc": ["0378-4275-93", "0378-4275-77", "0378-4276-93", "0378-4276-77"], "is_original_packager": [true], "unii": ["G447S0T1VC"]}, "product_type": "Drugs", "event_id": "94482", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the united states", "recall_number": "D-0481-2024", "product_description": "Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-4275-77", "product_quantity": "143,230 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.", "recall_initiation_date": "20240425", "center_classification_date": "20240502", "report_date": "20240508", "code_info": "Lot #: 3183269, Exp. Date May 2025; 3157326, Exp. date June 2024", "more_code_info": ""}, {"status": "Ongoing", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208845"], "brand_name": ["ZILRETTA"], "generic_name": ["TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION"], "manufacturer_name": ["Pacira Pharmaceuticals, Inc."], "product_ndc": ["65250-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR"], "rxcui": ["1947131", "1947133"], "spl_id": ["f5c73a99-9cc3-49f2-abaf-bbabfc33ba06"], "spl_set_id": ["cd5c4673-21f2-4126-9556-da847b3a228b"], "package_ndc": ["65250-003-01", "65250-001-01", "65250-002-01"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "94568", "recalling_firm": "PACIRA PHARMACEUTICALS INC", "address_1": "10578 Science Center Dr", "address_2": "N/A", "postal_code": "92121-1143", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide.", "recall_number": "D-0546-2024", "product_description": "Drug Vial Label: Zilretta\u00bf (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01.  Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01.  Carton Label: Drug Vial Label: Zilretta\u00bf (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01.", "product_quantity": "43,768 kits", "reason_for_recall": "Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.", "recall_initiation_date": "20240507", "center_classification_date": "20240607", "report_date": "20240619", "code_info": "Lot: 082657 (kit 23-9004), Exp: July 2024."}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0401-2024", "product_description": "fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.075% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095,  NDC 70004-0251-64, Bar Code 70004025164", "product_quantity": "130 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048722, Exp 11/29/23; 1223049096, Exp 12/15/23", "more_code_info": ""}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94648", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to CA, FL, OK, KS and CT", "recall_number": "D-0505-2024", "product_description": "Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03", "product_quantity": "66 bottles of 30 tablets", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit", "recall_initiation_date": "20240510", "center_classification_date": "20240521", "report_date": "20240529", "code_info": "Lot #: J2022G, Exp: 01/01/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0527-2024", "product_description": "NATURAL PAIN RELIEVING CREAM, GOLDEN TIGER, (Camphor 3%, Menthol 3%)Enriched with Capsaicin, Aloe Vera, Willow Bark & MSM, Tube 4 oz (113.39 g), Mfr. for Golden Tiger USA Albuq, NM, UPC 1 82294 00002 4", "product_quantity": "3,000", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 01623C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0455-2024", "product_description": "SILVERBACK XXX POWER MALE ENHANCEMENT, 2 fl. oz., UPC 8 700470 032762", "product_quantity": "7 pieces", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0405-2024", "product_description": "HYDROmorphone HCl 6 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = 0.2 mg/ml) 30 mL fill 35 mL Plungerless Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0300-16, Bar Code 70004030016", "product_quantity": "5,734 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048530, Exp 11/22/23; 1223048692 Exp 11/29/23; 1223048739 EXP  11/30/23; 1223048826 Exp 12/05/23; 1223048963 Exp 12/08/23; 1223048964 EXP  12/11/23; 1223049111 Exp 12/15/23; 1223049128 Exp12/19/23; 1223049210 EXP  12/21/23; 1223049234 Exp 12/22/23; 1223049257 Exp 12/22/23; 1223049322 Exp 12/27/23; 1223049416 Exp 12/28/23; 1223049528 Exp 01/03/24; 1223049559 Exp 01/04/24; 1223049614 Exp 01/05/24; 1223049632 Exp 01/08/24; 1223049725 Exp 01/11/24; 1223049792 Exp 01/15/24; 1223049793 Exp 01/15/24; 1223049905 Exp 01/19/24; 1223050029 Exp 1/24/24; 1223050061 Exp 01/25/24; 1223050179 Exp 01/29/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021067"], "brand_name": ["ASMANEX"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Organon LLC"], "product_ndc": ["78206-114", "78206-115"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["746803", "746804", "746810", "746811", "746812", "746813", "746814", "746815", "790283", "790284"], "spl_id": ["4742e310-f27e-4c57-97d2-29034ed8bea8"], "spl_set_id": ["10b36fb2-6b0d-4f20-b197-3564d6f594b9"], "package_ndc": ["78206-114-03", "78206-114-04", "78206-114-02", "78206-114-01", "78206-114-59", "78206-115-59", "78206-115-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "94703", "recalling_firm": "Organon Llc", "address_1": "30 Hudson St Fl 33", "address_2": "N/A", "postal_code": "07302-4804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0551-2024", "product_description": "Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-03", "product_quantity": "2,551 units", "reason_for_recall": "Defective Container", "recall_initiation_date": "20240528", "center_classification_date": "20240610", "report_date": "20240619", "code_info": "Lot #: X024051, Exp 04/25/2025"}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0456-2024", "product_description": "The GOAT SUBLINGUAL STRIP, MALE ENHANCEMENT, 2 Pack, Distributed by Hombres LLC, 130 Maccormick Ave, Suite 105, Costa Mesa, A, UPC 6 61631 26363 1.", "product_quantity": "10 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0425-2024", "product_description": "VANCOMYCIN 1.25 g added to 0.9% Sodium Chloride 250 mL Injection, 250 mL bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0923-59, Bar Code 70004092359", "product_quantity": "368 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049049 Exp 12/28/23", "more_code_info": ""}, {"status": "Terminated", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M002"], "brand_name": ["LITTLE REMEDIES"], "generic_name": ["SIMTHICONE"], "manufacturer_name": ["Medtech Products Inc."], "product_ndc": ["63029-103"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DIMETHICONE"], "rxcui": ["198857"], "spl_id": ["efeb43e2-a60e-4f51-81e5-f8c0db1f75be"], "spl_set_id": ["874d3f1d-1e4a-49ab-8285-4d6bf2601d5e"], "package_ndc": ["63029-103-01", "63029-103-02"], "is_original_packager": [true], "nui": ["N0000010282"], "pharm_class_pe": ["Skin Barrier Activity [PE]"], "unii": ["92RU3N3Y1O"]}, "product_type": "Drugs", "event_id": "94712", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "N/A", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Recalled units were distributed to one customer. 100% recovered (113,544 units) and controlled at Denison Pharmaceuticals.", "recall_number": "D-0557-2024", "product_description": "Little Remedies Gas Relief Drops (Simethicone/Antigas), packaged in 1 fl. oz. (30 mL) bottle with dropper, Dist by Medtech Products Inc., Tarrytown, NY 10591, NDC 63029-103-02", "product_quantity": "113,544 bottles", "reason_for_recall": "cGMP deviations: Test results confirmed aypical Burkholderia Cepacia were a result of personnel error.", "recall_initiation_date": "20240528", "center_classification_date": "20240617", "termination_date": "20250826", "report_date": "20240626", "code_info": "Lot #: 0855, Exp. 8/31/ 2025"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA206128"], "brand_name": ["METHOCARBAMOL"], "generic_name": ["METHOCARBAMOL"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-223"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METHOCARBAMOL"], "rxcui": ["238175"], "spl_id": ["980dbd07-e6d0-4d8a-8cbe-37c36c9e94c5"], "spl_set_id": ["e8e8da30-64cf-42ea-bf71-d085b0be8a09"], "package_ndc": ["55150-223-10"], "is_original_packager": [true], "nui": ["N0000175730", "N0000175737"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "unii": ["125OD7737X"]}, "product_type": "Drugs", "event_id": "94025", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0440-2024", "product_description": "Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10", "product_quantity": "1,552  10ml x 25/carton", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20240215", "center_classification_date": "20240408", "report_date": "20240417", "code_info": "Lot #: 3MC23011, Exp 11/30/2026"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["FENDALL 2000 PURE FLOW"], "generic_name": ["PURIFIED WATER"], "manufacturer_name": ["Honeywell Safety Products USA, Inc."], "product_ndc": ["0498-0631"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["WATER"], "rxcui": ["1053173"], "spl_id": ["0e4a17cb-beaf-6525-e063-6394a90a16b0"], "spl_set_id": ["b56ef662-fec2-4d94-e053-2995a90aba2b"], "package_ndc": ["0498-0631-37"], "is_original_packager": [true], "unii": ["059QF0KO0R"]}, "product_type": "Drugs", "event_id": "94345", "recalling_firm": "HONEYWELL INC", "address_1": "855 S Mint St", "address_2": "N/A", "postal_code": "28202", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Canada", "recall_number": "D-0461-2024", "product_description": "Eyesaline, Saline Eyewash Solution, Cartridge for Fendall 2000, Net contents: 7.9 gal per cartridge, Sperian Eye & Face Protection, Inc., 825 East Highway 151, Platteville, WI 53818.  NDC:  0498-0631-37", "product_quantity": "10, 605 cartridges", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240329", "center_classification_date": "20240423", "termination_date": "20240930", "report_date": "20240501", "code_info": "Manufacturer's Product Number/ Catalog Number: 32-002050-0000; Exp 06/21/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0409-2024", "product_description": "HYDROmorphone HCl 30 mg/30mL in 0.9% Sodium Chloride Injection, (Concentration = 1 mg/ml) 30 mL fill 35 mL Plungerless Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0303-16, Bar Code 70004030316", "product_quantity": "5392 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048357 Exp 11/15/23; 1223048461 EXP 11/20/23; 1223048486 EXP 11/21/23; 1223048694 EXP  12/01/23; 1223048865 EXP  12/06/23; 1223048967 EXP  12/11/23; 1223049098 EXP  12/15/23; 1223049133 EXP 12/19/23; 1223049175 EXP  12/20/23; 1223049268 EXP  12/25/23; 1223049457 EXP 01/01/24; 1223049561 EXP  01/04/24; 1223049604 EXP  01/05/24; 1223049648 EXP  01/09/24; 1223049870 EXP  01/17/24; 1223049942 EXP  01/19/24; 1223049973 EXP 01/23/24; 1223050060 EXP  01/25/24;", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0415-2024", "product_description": "PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 5 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-11, Bar Code 70004081011", "product_quantity": "7,198 syringes; expanded 1,289 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223045053 Exp 11/15/23; 1223046179 Exp 12/28/23; 1223047477 Exp 02/16/24; 1223047602 Exp 02/22/24; 1223047971 Exp 03/14/24; 1223048269 Exp 03/27/24  Expanded lot#: 1223048181, exp. date 03/22/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["GLOSTRIPS"], "generic_name": ["FLUORESCEIN SODIUM"], "manufacturer_name": ["Nomax Inc."], "product_ndc": ["51801-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["FLUORESCEIN SODIUM"], "spl_id": ["be8f6626-961d-48c3-ba7f-a2fae87c4cb6"], "spl_set_id": ["d06a4432-c76c-4e2a-abec-6bc5b4e82d51"], "package_ndc": ["51801-009-50", "51801-009-40"], "is_original_packager": [true], "unii": ["93X55PE38X"]}, "product_type": "Drugs", "event_id": "94461", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "N/A", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0463-2024", "product_description": "GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax, Inc., St. Louis, MO 63123, NDC 51801-009-40.", "product_quantity": "6,960 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.", "recall_initiation_date": "20240419", "center_classification_date": "20240423", "report_date": "20240501", "code_info": "Lot #: 14708, Exp. 04/30/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Charleston", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94447", "recalling_firm": "EPI Health, LLC", "address_1": "174 Meeting St Ste 200", "address_2": "N/A", "postal_code": "29401-3211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0473-2024", "product_description": "Cloderm (clocortolone pivalate) Cream, 0.1%, Rx Only, For Topical Use Only, Net Wt 45g, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-804-90", "product_quantity": "18645 tubes", "reason_for_recall": "CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.", "recall_initiation_date": "20240423", "center_classification_date": "20240425", "termination_date": "20240912", "report_date": "20240501", "code_info": "lot SDFC- exp. 5/31/2024 lot TFBW- exp. 5/31/2025", "more_code_info": ""}, {"status": "Completed", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090534"], "brand_name": ["NICARDIPINE HYDROCHLORIDE"], "generic_name": ["NICARDIPINE HYDROCHLORIDE"], "manufacturer_name": ["Civica, Inc."], "product_ndc": ["72572-470"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NICARDIPINE HYDROCHLORIDE"], "rxcui": ["858607"], "spl_id": ["fba70df6-5d37-4a12-bce3-e6fb1b0c72b2"], "spl_set_id": ["30fb3a4d-fa75-42fd-b4b6-2a21f202027f"], "package_ndc": ["72572-470-01", "72572-470-10"], "is_original_packager": [true], "unii": ["K5BC5011K3"]}, "product_type": "Drugs", "event_id": "94621", "recalling_firm": "American Regent, Inc.", "address_1": "6610 New Albany Rd E", "address_2": "", "postal_code": "43054-8730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "UT only", "recall_number": "D-0503-2024", "product_description": "niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054.  NDC 72572-470-10", "product_quantity": "4,136 cartons (10 vials in each carton)", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20240514", "center_classification_date": "20240521", "report_date": "20240529", "code_info": "Lot #: 23087N0C0, Exp. Date 11/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206127"], "brand_name": ["EPTIFIBATIDE"], "generic_name": ["EPTIFIBATIDE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-218", "55150-219", "55150-220"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["EPTIFIBATIDE"], "rxcui": ["200349", "1736470", "1736477"], "spl_id": ["944b269c-d810-411d-9ed4-8edd9d0ac1b7"], "spl_set_id": ["00ad7bbe-cadd-4647-b74b-adfc9f2b5e94"], "package_ndc": ["55150-218-99", "55150-219-10", "55150-220-99"], "is_original_packager": [true], "upc": ["0355150220991", "0355150219100"], "nui": ["N0000008832", "N0000175578"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Platelet Aggregation Inhibitor [EPC]"], "unii": ["NA8320J834"]}, "product_type": "Drugs", "event_id": "94680", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0556-2024", "product_description": "Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10", "product_quantity": "15,500 single dose vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.", "recall_initiation_date": "20240522", "center_classification_date": "20240614", "report_date": "20240626", "code_info": "Lot #: 3EF22003, Exp 6/30/2025"}, {"status": "Ongoing", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94461", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "N/A", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0464-2024", "product_description": "FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-403-03.", "product_quantity": "4648 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.", "recall_initiation_date": "20240419", "center_classification_date": "20240423", "report_date": "20240501", "code_info": "Lot 14842, Exp. 6/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125387"], "brand_name": ["EYLEA"], "generic_name": ["AFLIBERCEPT"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "product_ndc": ["61755-005"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVITREAL"], "substance_name": ["AFLIBERCEPT"], "rxcui": ["1232154", "1232159", "2693564", "2693567"], "spl_id": ["10b670d6-52e0-4eba-953b-c839ffb98014"], "spl_set_id": ["f96cfd69-da34-41ee-90a9-610a4655cd1c"], "package_ndc": ["61755-005-02", "61755-005-55", "61755-005-01", "61755-005-54", "8231500321", "8231500335", "8231500333", "8231500334", "8231500339", "8231500347"], "is_original_packager": [true], "nui": ["N0000193543", "N0000193542"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "unii": ["15C2VL427D"]}, "product_type": "Drugs", "event_id": "94481", "recalling_firm": "Regeneron Pharmaceuticals Inc", "address_1": "777 Old Saw Mill River Rd", "address_2": "", "postal_code": "10591-6717", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0479-2024", "product_description": "EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01", "product_quantity": "251,504 syringes", "reason_for_recall": "Lack of Assurance of Sterility: Complaints of syringe breakage", "recall_initiation_date": "20240423", "center_classification_date": "20240502", "termination_date": "20250925", "report_date": "20240508", "code_info": "Lot # 8231500321, Exp 10/31 24; 8231500335, 8231500333, 8231500334, 8231500339, 8231500347, Exp 1/30/25", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0520-2024", "product_description": "Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%),  Enriched with Capsaicin, Camphor, Menthol & MSM, Bottle with pump, NET WT 16 fluid oz / 473.17 ml, Made in USA, www.painwizard.com  Pain Wizard LLC.PO Box 1099, Johnstown, CO 80534, UPC 8 63865 00012 3", "product_quantity": "3,440", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot: 18723C3, Exp 06/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0523-2024", "product_description": "ALOE GATOR, (Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, Octyl Salicylate 5%),  Original Formula, SPF 40+, Broad Spectrum Protective Gel, Sport Performance, NET WT 1 OZ (28 g), Manufactured for AGS Brands.", "product_quantity": "4,013", "reason_for_recall": "Out of Specification for active ingredient", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 04023C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0530-2024", "product_description": "ALOE GATOR, (Octocrylene 8%, Octyl Methoxycinnamate 6%, Benzophone 3 6%, Octyl Salicylate 5%), SPF 40+, Broad Spectrum Protective Gel, Sport Performance, NET WT 4 OZ (113g), Manufactured for AGS Brands. UPC 0 17971 10421 7", "product_quantity": "6,264", "reason_for_recall": "Out of Specification for active ingredient", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 04023C1 Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212317"], "brand_name": ["DILTIAZEM HYDROCHLORIDE"], "generic_name": ["DILTIAZEM HYDROCHLORIDE"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "product_ndc": ["68462-562", "68462-850", "68462-851"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DILTIAZEM HYDROCHLORIDE"], "rxcui": ["830865", "830869", "830872"], "spl_id": ["52b392c0-72cb-4a91-8d27-5cacdb8a7778"], "spl_set_id": ["fb1606ea-1cff-46fd-b8e5-8135da76436c"], "package_ndc": ["68462-850-01", "68462-851-01", "68462-562-01"], "is_original_packager": [true], "upc": ["0368462562017", "0368462851012", "0368462850015"], "unii": ["OLH94387TE"]}, "product_type": "Drugs", "event_id": "94440", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0472-2024", "product_description": "Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.", "product_quantity": "3,264 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240417", "center_classification_date": "20240425", "report_date": "20240501", "code_info": "Lot #: 17221312, Exp. 5/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94750", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0561-2024", "product_description": "Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34", "product_quantity": "34,448 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240604", "center_classification_date": "20240618", "report_date": "20240626", "code_info": "Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024"}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0454-2024", "product_description": "libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box,  UPC 7 05105 83073 5.", "product_quantity": "7 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94271", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0437-2024", "product_description": "Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06", "product_quantity": "26,352 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20240321", "center_classification_date": "20240405", "termination_date": "20250404", "report_date": "20240417", "code_info": "Lot #: A201064, Exp. Date March 2024"}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA213510"], "brand_name": ["DOCETAXEL"], "generic_name": ["DOCETAXEL ANHYDROUS"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-254"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOCETAXEL ANHYDROUS"], "rxcui": ["1093280"], "spl_id": ["841e3024-e160-4c4b-93d3-1e79d628d95b"], "spl_set_id": ["6b227144-c844-4549-960c-cc3ac5c13b2b"], "package_ndc": ["25021-254-08", "25021-254-16"], "is_original_packager": [true], "nui": ["N0000175085", "N0000175592"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "unii": ["699121PHCA"]}, "product_type": "Drugs", "event_id": "94707", "recalling_firm": "Sagent Pharmaceuticals", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0553-2024", "product_description": "Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08", "product_quantity": "762 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.", "recall_initiation_date": "20240528", "center_classification_date": "20240612", "report_date": "20240619", "code_info": "Lot #: F1040001, Exp. Date 12/31/2024"}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0524-2024", "product_description": "Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%),  Enriched with Capsaicin, Camphor, Menthol & MSM, Tube, NET WT 8 oz (226.79g), Made in the USA, painwizard.com  PO Box 1099, Johnstown, CO 80534, UPC 8 63865 00011 6", "product_quantity": "7,410", "reason_for_recall": "Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lots 19823C4, EXP 07/31/2025; 01623C1, Exp 01/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206241"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1191", "70710-1192", "70710-1193", "70710-1194", "70710-1195"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632"], "spl_id": ["51a2adf6-a381-42cb-bf3e-8c83a7cfe738"], "spl_set_id": ["839fe7ae-6835-4d6a-b6b1-ca7f062caa4f"], "package_ndc": ["70710-1191-1", "70710-1191-8", "70710-1192-1", "70710-1192-8", "70710-1193-1", "70710-1193-8", "70710-1194-1", "70710-1194-8", "70710-1195-1", "70710-1195-8"], "is_original_packager": [true], "upc": ["0370710119188", "0370710119485", "0370710119287"], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "94649", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0542-2024", "product_description": "Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8", "product_quantity": "21,360 units", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20240516", "center_classification_date": "20240606", "report_date": "20240612", "code_info": "Lot #: M310493, Exp. Date 01/2025; M308397, Exp. Date 11/2024; M305337, Exp. Date      10/2024; M400155, Exp. Date 06/2025; M314660, Exp. Date 05/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076784"], "brand_name": ["TRI-LO-SPRINTEC"], "generic_name": ["NORGESTIMATE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2140"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["578732", "748797", "749155", "749156", "749157", "856467"], "spl_id": ["204ad27b-376e-4d07-bf27-1db57f446045"], "spl_set_id": ["ddbeb312-af2b-4d22-ab7c-5ab2f3f8d5cb"], "package_ndc": ["0093-2140-28", "0093-2140-62"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "94183", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0428-2024", "product_description": "Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62", "product_quantity": "92,676 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240307", "center_classification_date": "20240328", "termination_date": "20250306", "report_date": "20240403", "code_info": "Lot # 100039678, Exp 04/31/2024; 100038111, 100042277, Exp 07/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA215307"], "brand_name": ["DIGOXIN"], "generic_name": ["DIGOXIN"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["70954-200", "70954-201", "70954-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIGOXIN"], "rxcui": ["197604", "197606", "245273"], "spl_id": ["ee465d1a-f5ee-477b-b20e-3ce8705e7472"], "spl_set_id": ["dba3b3f7-3ff2-4996-8653-b0e54a398bf9"], "package_ndc": ["70954-201-10", "70954-201-20", "70954-202-10", "70954-202-20", "70954-200-10"], "is_original_packager": [true], "upc": ["0370954201106", "0370954201205", "0370954202103", "0370954200109"], "nui": ["N0000175568", "M0003451"], "pharm_class_epc": ["Cardiac Glycoside [EPC]"], "pharm_class_cs": ["Cardiac Glycosides [CS]"], "unii": ["73K4184T59"]}, "product_type": "Drugs", "event_id": "94255", "recalling_firm": "Novitium Pharma LLC", "address_1": "70 Lake Dr", "address_2": "", "postal_code": "08520-5321", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0443-2024", "product_description": "Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10", "product_quantity": "1,003 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240325", "center_classification_date": "20240413", "termination_date": "20240716", "report_date": "20240424", "code_info": "Lot M23011A; Exp. 12/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94354", "recalling_firm": "ARG Laboratories, Inc.", "address_1": "2639 Manana Dr", "address_2": "", "postal_code": "75220-1301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0522-2024", "product_description": "Bull Frog SPF 50 Amphibious Lotion SPF 50 Amphibious Lotion with Water Armor Tech, Broad Spectrum Sunscreen with UVA/UVB Protection, NEW WT. 5 FL OZ (148ML), Distributed by: Bullfrog Brands LLC, PO Box 600207, Dallas, TX 75360 USA. UPC 8 50016 52112 5", "product_quantity": "9,697", "reason_for_recall": "Out of Specification for active ingredient", "recall_initiation_date": "20240417", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot 08623C2, 08923C2, Exp 03/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Bryant Ranch Prepack"], "product_ndc": ["63629-9207"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309113"], "spl_id": ["f1e8edf5-5ad5-4e90-9f40-7b3a36df7f85"], "spl_set_id": ["e186afb5-7531-45ea-b785-c230483a7747"], "package_ndc": ["63629-9207-1"], "original_packager_product_ndc": ["67877-545"], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "94605", "recalling_firm": "Bryant Ranch Prepack, Inc.", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0540-2024", "product_description": "Cephalexin for Oral Suspension, USP, 250mg/5mL, Rx only, 200mL (when mixed), Each contains cephalexin monohydrate, USP equivalent to 5g cephalexin. Manufactured by Alkem Laboratories Ltd, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9207-1.", "product_quantity": "61 Bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g'  instead of  Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g'", "recall_initiation_date": "20240510", "center_classification_date": "20240604", "report_date": "20240612", "code_info": "Lot: 235067, Exp 12/31/2025; 235289, Exp 11/30/2025; 235290, Exp 12/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94553", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0519-2024", "product_description": "Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-640-01", "product_quantity": "74,440 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240530", "report_date": "20240605", "code_info": "Lot #: 23JUL025, Exp. Date 7/17/2024; 23SEP012, Exp. Date 7/11/2024; 23OCT015, Exp. Date 7/20/2024; 23OCT020, Exp. Date 7/25/2024; 23OCT026, Exp. Date 8/22/2024; 23NOV030, Exp. Date 8/29/2024, 23DEC026, Exp. Date 9/29/2024; 24JAN011, Exp. Date 7/21/2024;  24FEB033, Exp. Date 8/24/2024; 24JAN050, Exp. Date 8/30/2024", "more_code_info": ""}, {"status": "Completed", "city": "Ann Arbor", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA211617"], "brand_name": ["NEXLIZET"], "generic_name": ["BEMPEDOIC ACID AND EZETIMIBE"], "manufacturer_name": ["Esperion Therapeutics, Inc."], "product_ndc": ["72426-818"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BEMPEDOIC ACID", "EZETIMIBE"], "spl_id": ["ded66e40-dc19-4b24-ad70-cdcafb34d901"], "spl_set_id": ["3fa2108c-0300-47b8-9d34-f762af7c93c6"], "package_ndc": ["72426-818-03", "72426-818-09", "72426-818-99"], "is_original_packager": [true], "nui": ["N0000193913", "N0000193914", "N0000008553", "N0000175911"], "pharm_class_epc": ["Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["1EJ6Z6Q368", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "94365", "recalling_firm": "Esperion", "address_1": "3891 Ranchero Dr Ste 150", "address_2": "", "postal_code": "48108-2837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0441-2024", "product_description": "NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03", "product_quantity": "3,480 30-count bottles", "reason_for_recall": "Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.", "recall_initiation_date": "20240327", "center_classification_date": "20240412", "report_date": "20240424", "code_info": "Lot #,  1990305, Exp 08-31-2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021067"], "brand_name": ["ASMANEX"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Organon LLC"], "product_ndc": ["78206-114", "78206-115"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["746803", "746804", "746810", "746811", "746812", "746813", "746814", "746815", "790283", "790284"], "spl_id": ["4742e310-f27e-4c57-97d2-29034ed8bea8"], "spl_set_id": ["10b36fb2-6b0d-4f20-b197-3564d6f594b9"], "package_ndc": ["78206-114-03", "78206-114-04", "78206-114-02", "78206-114-01", "78206-114-59", "78206-115-59", "78206-115-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "94703", "recalling_firm": "Organon Llc", "address_1": "30 Hudson St Fl 33", "address_2": "N/A", "postal_code": "07302-4804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0550-2024", "product_description": "Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 60 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-02", "product_quantity": "2,886 units", "reason_for_recall": "Defective Container", "recall_initiation_date": "20240528", "center_classification_date": "20240610", "report_date": "20240619", "code_info": "Lot #: X025346, Exp 3/3/2025"}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA215338"], "brand_name": ["VANCOMYCIN HYDROCHLORIDE"], "generic_name": ["VANCOMYCIN HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-2261"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VANCOMYCIN HYDROCHLORIDE"], "rxcui": ["2000134"], "spl_id": ["4709fe67-0ab3-4727-950f-b926a7bb21df"], "spl_set_id": ["3c47d5c4-8cdb-4701-8d7a-8a6e79025b53"], "package_ndc": ["69238-2261-3", "69238-2261-7", "69238-2261-5"], "is_original_packager": [true], "upc": ["0369238226157", "0369238226133", "0369238226171"], "unii": ["71WO621TJD"]}, "product_type": "Drugs", "event_id": "94262", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0442-2024", "product_description": "Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC 69238-2261-3; (b) 150 mL bottle, NDC 69238-2261-7; (c)300 mL bottle,  NDC 69238-2261-5; Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807", "product_quantity": "821 bottles", "reason_for_recall": "Superpotent Drug:  Due to overfilling of drug powder", "recall_initiation_date": "20240321", "center_classification_date": "20240412", "termination_date": "20250721", "report_date": "20240424", "code_info": "Lot # (a) 22613003A, Exp. date 09/30/2025; (b) 22613004A, 22613005A, Exp. date 09/30/2025; (c) 22613005B, Exp. date 09/30/2025", "more_code_info": ""}, {"status": "Completed", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"brand_name": ["SODIUM SULFACETAMIDE 10 SULFUR 5 CLEANSER"], "generic_name": ["SULFACETAMIDE SODIUM AND SULFUR"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-136"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["SULFACETAMIDE SODIUM", "SULFUR"], "spl_id": ["679caef9-ee89-4c41-abfb-1987997729fc"], "spl_set_id": ["1926eadd-d11f-44fa-971f-0041060f7589"], "package_ndc": ["42192-136-06", "42192-136-08", "42192-136-12"], "is_original_packager": [true], "unii": ["4NRT660KJQ", "70FD1KFU70"]}, "product_type": "Drugs", "event_id": "94485", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110", "address_2": "N/A", "postal_code": "30005-1795", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico.", "recall_number": "D-0490-2024", "product_description": "Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, Rx Only, 6 oz (170.3 g) Bottle, Manufactured for Acela Pharmaceuticals, LLC Alphareta, GA 30005, NDC 42192-136-06", "product_quantity": "7104 Bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20240424", "center_classification_date": "20240508", "report_date": "20240515", "code_info": "Lot # 22085 Exp. date 08/02/2024"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94738", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one medical facility.", "recall_number": "D-0549-2024", "product_description": "Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA", "product_quantity": "8 bottles", "reason_for_recall": "Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.", "recall_initiation_date": "20240531", "center_classification_date": "20240610", "termination_date": "20240701", "report_date": "20240619", "code_info": "Lot # B2906961-042524, exp. date 02/26/2027"}, {"status": "Ongoing", "city": "Tokushima", "state": "N/A", "country": "Japan", "classification": "Class III", "openfda": {"application_number": ["NDA021436"], "brand_name": ["ABILIFY"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Otsuka America Pharmaceutical, Inc."], "product_ndc": ["59148-006", "59148-007", "59148-008", "59148-009", "59148-010", "59148-011"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "352307", "352308", "352309", "352310", "402131", "404602", "602964", "615172"], "spl_id": ["1b189d15-798d-4bed-a93d-a543ed7abd81"], "spl_set_id": ["c040bd1d-45b7-49f2-93ea-aed7220b30ac"], "package_ndc": ["59148-006-13", "59148-006-92", "59148-007-13", "59148-007-35", "59148-007-94", "59148-008-13", "59148-008-35", "59148-008-95", "59148-009-13", "59148-009-35", "59148-009-95", "59148-010-13", "59148-010-35", "59148-011-13", "59148-011-35"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "94382", "recalling_firm": "Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.", "address_1": "224-18", "address_2": "Kawauchi-Cho", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0469-2024", "product_description": "Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13", "product_quantity": "N/A", "reason_for_recall": "Cross Contamination with Other Products", "recall_initiation_date": "20240409", "center_classification_date": "20240423", "report_date": "20240501", "code_info": "Lot # APS00423A, Exp 07/31/2025; APS00222A, Exp 11/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203730"], "brand_name": ["DIVALPROEX SODIUM"], "generic_name": ["DIVALPROEX SODIUM"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-755", "65162-757"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIVALPROEX SODIUM"], "rxcui": ["1099563", "1099569"], "spl_id": ["04a80ebc-8c7b-4358-b815-60c334edc37f"], "spl_set_id": ["7d3352ee-a240-43ff-a243-29ad2bc989c7"], "package_ndc": ["65162-755-10", "65162-755-50", "65162-757-10", "65162-757-50"], "is_original_packager": [true], "upc": ["0365162755107", "0365162757101"], "unii": ["644VL95AO6"]}, "product_type": "Drugs", "event_id": "93976", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0426-2024", "product_description": "Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad, INDIA, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 65162-755-10. NDC# 65162-755-10", "product_quantity": "21,452/100 count bottles", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20231226", "center_classification_date": "20240327", "termination_date": "20240816", "report_date": "20240403", "code_info": "Lot # AR210704, exp. date 04/2024 AR210706, exp. date 04/2024 AR210707, exp. date 04/2024 AR210708, exp. date 04/2024 AR210709, exp. date 04/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Fenton", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94198", "recalling_firm": "SSM Health Care St. Louis DBA SSM St. Clare Health Center", "address_1": "1015 Bowles Ave", "address_2": "", "postal_code": "63026-2394", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MO", "recall_number": "D-0436-2024", "product_description": "FentaNYL citrate, 10 mcg in 0.9% Sodium Chloride 1 mL Vial (10 mcg/mL), 1.5 mL Total Volume per Vial, Intravenous, Rx Only, Hospital/Office Use Only, SSM Health Care Corporation Outsourcing Facility, 1015 Bowles Ave, Fenton, MO 63026-2394.  NDC: 60652-9010-1", "product_quantity": "140 vials", "reason_for_recall": "Lack of Assurance of Sterility: Firm did not perform process validation.", "recall_initiation_date": "20240229", "center_classification_date": "20240404", "report_date": "20240410", "code_info": "Lot: 20231031-0C91D9, Exo 29-Feb-2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94551", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0513-2024", "product_description": "Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-512-01", "product_quantity": "39,700 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240529", "report_date": "20240605", "code_info": "Lot #: 23MAY016, Exp. Date 5/8/24; 23JUL016, Exp. Date 7/10/24; 23AUG034, Exp. Date 8/16/24; 23DEC014, Exp. Date 12/10/24", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0423-2024", "product_description": "SUCcinylcholine Chloride 200 mg/10mL Injection (Concentration = 20mg/mL), 10 mL fill 12 mL Syringe, Rx only, Repackaged by SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0908-12, Bar Code 70004090812", "product_quantity": "8,755 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049047 Exp 11/29/23; 1223049221 Exp 12/06/23; 1223049343 Exp 12/12/23; 1223049423 Exp 12/14/23; 1223049451 Exp 12/14/23; 1223049452 Exp 12/14/23; 1223049482 Exp 12/14/23", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0416-2024", "product_description": "PHENYLephrine HCl 500 mcg/5 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 5 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0810-11-K, Bar Code 70004081011. (same finished product as F078140, but with RFID for KitCheck", "product_quantity": "1,118 syringes in kits", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048431 exp 04/05/24; 1223049023 exp 04/25/24", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0396-2024", "product_description": "fentaNYL 2,500 mcg/50 mL Injection (Concentration = 50 mcg/mL), INTRAVENOUS USE ONLY, 50 mL Bag, Rx only, SCA Pharma, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0222-30 BAR code 70004022230", "product_quantity": "500 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048351, Exp 11/30/23; 1223048532, Exp 12/07/23", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201967"], "brand_name": ["RIZATRIPTAN BENZOATE"], "generic_name": ["RIZATRIPTAN BENZOATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-465", "68462-466"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIZATRIPTAN BENZOATE"], "rxcui": ["312840", "314209"], "spl_id": ["c7909d7b-34a6-42b0-ad12-eb25f3ce886e"], "spl_set_id": ["99c66300-bd75-4b31-9fab-88c6e4b12688"], "package_ndc": ["68462-465-72", "68462-465-99", "68462-466-72", "68462-466-99"], "is_original_packager": [true], "upc": ["0368462465998", "0368462466995"], "unii": ["WR978S7QHH"]}, "product_type": "Drugs", "event_id": "94606", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0533-2024", "product_description": "Rizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Product of India, NDC 68462-466-99", "product_quantity": "11,976 cartons", "reason_for_recall": "CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.", "recall_initiation_date": "20240510", "center_classification_date": "20240604", "report_date": "20240612", "code_info": "Lot#: 19224217; Exp. 9/2024 Lot#: 19233789; Exp. 9/2025 Lot#: 19224444; Exp. 9/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0397-2024", "product_description": "fentaNYL 200 mcg/100 mL, Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 2 mcg/mL), EPIDURAL USE ONLY, 100 mL Bag, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0231-32, Bar Code 70004023132", "product_quantity": "242 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223048855, Exp 12/6/23", "more_code_info": ""}, {"status": "Terminated", "city": "Horseheads", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94348", "recalling_firm": "X-Gen Pharmaceuticals Inc.", "address_1": "300 Daniel Zenker Dr", "address_2": "", "postal_code": "14845-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0433-2024", "product_description": "Cyclophosphamide for Injection, USP, 500mg/vial, Lyophilized, Cytotoxic Agent, Single Dose Vial for Intravenous Use, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc. Big Flats, NY 14814, NDC # 39822-0250-01.", "product_quantity": "1283 vials", "reason_for_recall": "Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.", "recall_initiation_date": "20240402", "center_classification_date": "20240404", "termination_date": "20250930", "report_date": "20240410", "code_info": "Lot #: CIC1-23001 A, Exp. 08/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091363"], "brand_name": ["ZOLEDRONIC ACID"], "generic_name": ["ZOLEDRONIC ACID"], "manufacturer_name": ["Dr.Reddy's Laboratories Ltd"], "product_ndc": ["55111-688"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ZOLEDRONIC ACID"], "rxcui": ["705824"], "spl_id": ["251add88-5c4f-2750-c713-744fcf3a60ba"], "spl_set_id": ["f94a5c9e-74bc-d09e-cd65-394b2a5de2ad"], "package_ndc": ["55111-688-52"], "is_original_packager": [true], "upc": ["0355111688525"], "unii": ["6XC1PAD3KF"]}, "product_type": "Drugs", "event_id": "94686", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0510-2024", "product_description": "Zoledronic Acid Injection 5mg/100mL Sterile Solution, 100mL Single-Dose vials, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-688-52", "product_quantity": "13,880 vials", "reason_for_recall": "Lack of Assurance of Sterility: Leaking vials", "recall_initiation_date": "20240523", "center_classification_date": "20240528", "report_date": "20240605", "code_info": "Lot #: G3000010, Exp. Date 11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065259"], "brand_name": ["CEFDINIR"], "generic_name": ["CEFDINIR"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-722", "68180-723"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFDINIR"], "rxcui": ["309054", "476576"], "spl_id": ["b32b7bfb-4770-4da0-8c48-684233cd10c9"], "spl_set_id": ["7490df67-56c0-4a1c-8533-2107f3e8aea5"], "package_ndc": ["68180-722-20", "68180-722-10", "68180-722-04", "68180-722-05", "68180-723-20", "68180-723-10", "68180-723-04", "68180-723-05"], "is_original_packager": [true], "upc": ["0368180723042"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["CI0FAO63WC"]}, "product_type": "Drugs", "event_id": "94492", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0497-2024", "product_description": "Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046, India, NDC 68180-722-04", "product_quantity": "17,040 bottles", "reason_for_recall": "Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.", "recall_initiation_date": "20240424", "center_classification_date": "20240514", "termination_date": "20250429", "report_date": "20240522", "code_info": "Lot # F305292, Exp 8/30/2025"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94554", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "N/A", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide", "recall_number": "D-0547-2024", "product_description": "Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug. NOT FOR RESALE. OFFICE USE ONLY  Compounded by: Imprimis NJOF, LLC., 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852 NDC: 71384-514-05", "product_quantity": "136,005 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240607", "report_date": "20240619", "code_info": "Lot:23APR005  Exp. 5/1/2024  Lot:23MAY024  Exp. 5/15/2024  Lot:23JUN010  Exp. 5/30/2024  Lot:23JUN016  Exp. 6/7/2024  Lot:23JUN047  Exp. 7/4/2024  Lot:23JUL013  Exp. 7/11/2024  Lot:23JUL029  Exp. 7/25/2024  Lot:23JUL030       Exp. 8/1/2024  Lot:23AUG016  Exp. 8/7/2024  Lot:23AUG042  Exp. 9/27/2024  Lot:23SEP017  Exp. 7/13/2024  Lot:23OCT039  Exp. 8/3/2024  Lot:23NOV022  Exp. 8/24/2024  Lot:23NOV036  Exp. 8/29/2024  Lot:23DEC021  Exp. 10/4/2024  Lot:24JAN018  Exp. 10/11/2024  Lot:24JAN026  Exp. 10/24/2024  Lot:24JAN040  Exp. 11/2/2024  Lot:24FEB021  Exp. 11/16/2024  Lot:24MAR005  Exp. 12/12/2024"}, {"status": "Terminated", "city": "Charleston", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94447", "recalling_firm": "EPI Health, LLC", "address_1": "174 Meeting St Ste 200", "address_2": "N/A", "postal_code": "29401-3211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0474-2024", "product_description": "minolira (minocycline hydrochloride) extended-release tablets, 105mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-101-30.", "product_quantity": "12808 bottles", "reason_for_recall": "CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.", "recall_initiation_date": "20240423", "center_classification_date": "20240425", "termination_date": "20240912", "report_date": "20240501", "code_info": "lot # T2300765- exp. 11/30/2025 lot# T2201702A-exp. 02/28/2025 lot# T2201699- exp. 2/28/2025 lot# T2201698- exp. 2/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Jersey City", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94703", "recalling_firm": "Organon Llc", "address_1": "30 Hudson St Fl 33", "address_2": "N/A", "postal_code": "07302-4804", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0552-2024", "product_description": "Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 30 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-0114-04", "product_quantity": "0", "reason_for_recall": "Defective Container", "recall_initiation_date": "20240528", "center_classification_date": "20240610", "report_date": "20240619", "code_info": "Lot #: Y000085, Exp 4/25/2025"}, {"status": "Ongoing", "city": "Ledgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94551", "recalling_firm": "Imprimis NJOF, LLC", "address_1": "1705 Route 46 Ste 6B", "address_2": "", "postal_code": "07852-9720", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0512-2024", "product_description": "Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-640-01", "product_quantity": "14,180 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240514", "center_classification_date": "20240529", "report_date": "20240605", "code_info": "Lot #: 23APR033, Exp. Date 5/1/24; 23JUN001, Exp. Date 6/5/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Bryant Ranch Prepack"], "product_ndc": ["63629-9204"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309110"], "spl_id": ["b7e7ec11-dee5-4ed2-ad3d-be967d311e26"], "spl_set_id": ["f4ced8c7-a276-4a44-a60c-f8d1689a2bdf"], "package_ndc": ["63629-9204-1"], "original_packager_product_ndc": ["67877-544"], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "94605", "recalling_firm": "Bryant Ranch Prepack, Inc.", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0536-2024", "product_description": "Cephalexin for Oral Suspension, USP, 125mg per 5mL, Rx only, 100 Tablets, Relabeled by: Bryant Ranch Prepack, Inc, Burbank, CA 91504, NDC 63629-9204-1.", "product_quantity": "156 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified: Front label states   100 Tablets  instead of  100 ml  and on the back label 'Each Tablet contains' instead of 'Each Bottle contains' No total dose per bottle listed should be 2.5 g'", "recall_initiation_date": "20240510", "center_classification_date": "20240604", "report_date": "20240612", "code_info": "Lot:225541, 226866, 227369, 227519, 229845, 231422, 234889, Exp: 03/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "94265", "recalling_firm": "Pyramids Wholesale Inc.", "address_1": "464 E 4th St", "address_2": "N/A", "postal_code": "90013-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0453-2024", "product_description": "GoHARD 25000, Male Sexual Enhancement, Honey, 100% Natural, UPC: N/A.", "product_quantity": "12 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.", "recall_initiation_date": "20240319", "center_classification_date": "20240422", "report_date": "20240501", "code_info": "All lots", "more_code_info": ""}]